United States Healthcare Providers & Services

Cigna Group (CI)

Track

Over the last 90 days, Cigna Group has seen significant insider selling, totaling over $118 million. Notably, Chairman & CEO David Cordani executed multiple planned and proposed sales, amounting to substantial value. No insider purchases were recorded during this period. The stock has experienced a slight decline of 0.3% over the past 90 days.
Stock chart
Ticker: CI Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cordani David
Chairman & CEO
14 sales — total 118,228,372 USD
Planned sale 12 May 2026
Value US$4,875,033.03 | Price 234.49 | Shares 38,675
Planned sale 12 May 2026
Value US$2,401,180.96 | Price 419.21 | Shares 98,431
Planned sale 12 May 2026
Value US$598,717.61 | Price 296.84 | Shares 2,017
Planned sale 12 May 2026
Value US$10,253,195.60 | Price 295.98 | Shares 34,641
Planned sale 12 May 2026
Value US$11,352,887.56 | Price 294.98 | Shares 38,487
Planned sale 12 May 2026
Value US$629,574.50 | Price 293.92 | Shares 2,142
Planned sale 12 May 2026
Value US$2,302,310.81 | Price 292.88 | Shares 7,861
Planned sale 12 May 2026
Value US$3,595,313.76 | Price 291.95 | Shares 12,315
Planned sale 12 May 2026
Value US$3,996,088.90 | Price 291.01 | Shares 13,732
Planned sale 12 May 2026
Value US$11,918,783.98 | Price 290.00 | Shares 41,099
Planned sale 12 May 2026
Value US$3,997,456.04 | Price 288.85 | Shares 13,839
Planned sale 12 May 2026
Value US$4,115,590.06 | Price 287.96 | Shares 14,292
Planned sale 12 May 2026
Value US$1,119,505.30 | Price 286.83 | Shares 3,903
Proposed sale 12 May 2026
Value US$59,114,186.14 | Price 292.82 | Shares 201,878
Planned sale 2 Mar 2026
Value US$3,332,314.08 | Price 31.48 | Shares 17,730
Proposed sale 2 Mar 2026
Value US$2,788,478.12 | Price 123.89 | Shares 62,424
Planned sale 2 Mar 2026
Value US$666,515.37 | Price 288.91 | Shares 2,307
Proposed sale 2 Mar 2026
Value US$666,515.37 | Price 288.91 | Shares 2,307
Proposed sale 6 Feb 2026
Value US$1,791,895.21 | Price 293.32 | Shares 6,109
Buy 3 Nov 2025
Value US$999,916.21 | Price 241.88 | Shares 4,134
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
38,675 -10.9%
234.49
US$4,875,033 		38,675 -10.9% 234.49 US$4,875,033
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
98,431 +44.6%
419.21
US$2,401,181 		98,431 +44.6% 419.21 US$2,401,181
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
9,968 +28.5%
432.82
US$1,420,003 		9,968 +28.5% 432.82 US$1,420,003
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
34,641 -39.1%
295.98
US$10,253,196 		34,641 -39.1% 295.98 US$10,253,196
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
38,487 -30.3%
294.98
US$11,352,888 		38,487 -30.3% 294.98 US$11,352,888
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
2,142 -1.7%
293.92
US$629,574 		2,142 -1.7% 293.92 US$629,574
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
7,861 -5.7%
292.88
US$2,302,311 		7,861 -5.7% 292.88 US$2,302,311
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
12,315 -8.2%
291.95
US$3,595,314 		12,315 -8.2% 291.95 US$3,595,314
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
13,732 -8.4%
291.01
US$3,996,089 		13,732 -8.4% 291.01 US$3,996,089
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
41,099 -20.1%
290.00
US$11,918,784 		41,099 -20.1% 290.00 US$11,918,784
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
13,839 -6.3%
288.85
US$3,997,456 		13,839 -6.3% 288.85 US$3,997,456
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
14,292 -6.2%
287.96
US$4,115,590 		14,292 -6.2% 287.96 US$4,115,590
2026-05-14 2026-05-12 PlS Planned sale
3.3
Cordani David

Chairman & CEO

Executive Director
3,903 -1.7%
286.83
US$1,119,505 		3,903 -1.7% 286.83 US$1,119,505
2026-05-12 2026-05-12 PrS Proposed sale
3.3
Cordani David

Officer; Director

Executive Director
201,878
292.82
US$59,114,186 		201,878 292.82 US$59,114,186
2026-03-03 2026-03-02 PlS Planned sale
Neville Everett

See Remarks

Officer
1,719 -23.3%
288.91
US$496,636 		1,719 -23.3% 288.91 US$496,636
2026-03-03 2026-03-02 PlS Planned sale
Jones Nicole S

See Remarks

Officer
2,307 -6.6%
288.91
US$666,515 		2,307 -6.6% 288.91 US$666,515
2026-03-02 2026-03-02 PrS Proposed sale
Jones Nicole S

Officer

Officer
2,307
288.91
US$666,515 		2,307 288.91 US$666,515
2026-03-02 2026-03-02 PrS Proposed sale
Neville Everett

Officer

Officer
1,719
288.91
US$496,636 		1,719 288.91 US$496,636
2026-02-06 2026-02-06 PrS Proposed sale
Granger Elder

Former Director

Non-Executive Director
6,109
293.32
US$1,791,895 		6,109 293.32 US$1,791,895
2025-11-03 2025-11-03 B Purchase
3.3
Cordani David

Chairman & CEO

Executive Director
4,134 +2.7%
241.88
US$999,916 		4,134 +2.7% 241.88 US$999,916
Explore more

More insider trading research around Cigna Group

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America
Insider trades in S&P 500